Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E)Christopher Yasenchak,Rodolfo Bordoni,Dipti Patel-Donnelly,Timothy Larson,Jerome Goldschmidt,Ralph Boccia,Vivian J. M. Cline, Shweta Jain,Jingmin Liu, Joseph Thaddeus BeckBLOOD(2023)引用 1|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要